Ligand validation:5BTD

GFN: 1-cyclopropyl-6-fluoro-8-methoxy-7-[(3S)-3-methylpiperazin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

GFN is a Ligand Of Interest in 5BTD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5BTD_GFN_E_101	40%	14%	0.222	0.936	1.46	2.34	5	7	0	0	100%	1
5BTD_GFN_G_101	36%	14%	0.243	0.94	1.46	2.38	6	6	0	0	100%	1
5BTF_GFN_F_101	26%	14%	0.276	0.919	1.48	2.38	6	6	0	0	100%	1
7F35_GFN_A_301	61%	33%	0.194	0.986	0.88	1.73	2	9	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.